NORMODYNE: LABETALOL HYDROCHLORIDE INJECTIO.
LABETALOL HYDROCHLORIDE INJECTIO. Key specifications include administration: INTRAVENOUS, coating_feature: FILM, NONENTERIC, special_features: SINGLE DOSE; PREFILLED; DISPOSABLE SYRINGE, primary_container_type: SYRINGE-NEEDLE UNIT, protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-197-4180, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| coating_feature | FILM, NONENTERIC |
| special_features | SINGLE DOSE; PREFILLED; DISPOSABLE SYRINGE |
| primary_container_type | SYRINGE-NEEDLE UNIT |
| protective_storage_feature | SUBJECT TO DAMAGE BY FREEZING |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 4.000 MILLILITERS |
| active_medicament_medicinal_strength | 5.000 MILLIGRAMS LABETALOL HYDROCHLORIDE PER MILLILITER |
| part_name_assigned_by_controlling_agency | LABETALOL HYDROCHLORIDE INJECTION USP 5MG/ML 4ML SYRINGE-NEEDLE |
| NSN | 6505-01-197-4180 |
| COATING FEATURE | FILM, NONENTERIC |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LABETALOL HYDROCHLORIDE TABLETS 300MG 100S BT |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 300.000 MILLIGRAMS LABETALOL HYDROCHLORIDE ACTIVE INGREDIENT |